Cargando…

Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

Type I Interferonopathies comprise inherited inflammatory diseases associated with perturbation of the type I IFN response. Use of Janus kinase (JAK) inhibitors has been recently reported as possible tools for treating some of those rare diseases. We describe herein the clinical picture and treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cattalini, Marco, Galli, Jessica, Zunica, Fiammetta, Ferraro, Rosalba Monica, Carpanelli, Marialuisa, Orcesi, Simona, Palumbo, Giovanni, Pinelli, Lorenzo, Giliani, Silvia, Fazzi, Elisa, Badolato, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578119/ https://www.ncbi.nlm.nih.gov/pubmed/34778129 http://dx.doi.org/10.3389/fped.2021.725868

Ejemplares similares

Treatment response to Janus kinase inhibitor in a child affected by Aicardi‐Goutières syndrome
por: Galli, Jessica, et al.
Publicado: (2023)

IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report
por: Badolato, Raffaele, et al.
Publicado: (2021)

Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis
por: Galli, Jessica, et al.
Publicado: (2018)

Family History of Autoimmune Disease in Patients with Aicardi-Goutières Syndrome
por: Schmidt, Johanna L., et al.
Publicado: (2012)

DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes
por: Giordano, Anna Maria Sole, et al.
Publicado: (2022)

Comparison between D-loop methylation and mtDNA copy number in patients with Aicardi-Goutières Syndrome
por: Dragoni, Francesca, et al.
Publicado: (2023)

MRI Features Predictive of Aicardi-Goutieres Syndrome
por: Millichap, J. Gordon
Publicado: (2015)

Aicardi–Goutières Syndrome: Brief Case Report
por: Moscote-Salazar, Luis Rafael, et al.
Publicado: (2018)

3358 Developmental Outcomes of Aicardi Goutieres Syndrome
por: Adang, Laura, et al.
Publicado: (2019)

Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib
por: Pararajasingam, Abirami, et al.
Publicado: (2022)

Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain
por: Guo, Xinfeng, et al.
Publicado: (2021)

JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study
por: Frémond, Marie-Louise, et al.
Publicado: (2023)

Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib
por: Wang, Wei, et al.
Publicado: (2023)

Interferon-α and the calcifying microangiopathy in Aicardi–Goutières syndrome
por: Klok, Melanie D, et al.
Publicado: (2015)

Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review
por: Garau, Jessica, et al.
Publicado: (2019)

Characterization of Mitochondrial Alterations in Aicardi–Goutières Patients Mutated in RNASEH2A and RNASEH2B Genes
por: Dragoni, Francesca, et al.
Publicado: (2022)

Endocrinopathies in Aicardi Goutières syndrome—A descriptive case series
por: Worth, Chris, et al.
Publicado: (2020)

Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China
por: Wang, Wei, et al.
Publicado: (2022)

Case Report: Novel Compound Heterozygous RNASEH2B Mutations Cause Aicardi–Goutières Syndrome
por: Garau, Jessica, et al.
Publicado: (2021)

Reduction of hRNase H2 activity in Aicardi–Goutières syndrome cells leads to replication stress and genome instability
por: Pizzi, Sara, et al.
Publicado: (2015)

Relapsing–remitting clinical course expands the phenotype of Aicardi–Goutières syndrome
por: Lambe, Jeffrey, et al.
Publicado: (2020)

Interstitial Lung Disease and Psoriasis in a Child With Aicardi-Goutières Syndrome
por: Zheng, Shaoling, et al.
Publicado: (2020)

Incidence of Aicardi-Goutières syndrome and KCNT1-related epilepsy in Denmark
por: Møller, Rikke S., et al.
Publicado: (2022)

Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi–Goutières Syndrome Phenotype
por: Peixoto de Barcelos, Isabella, et al.
Publicado: (2023)

Recurrent Encephalopathy with Spinal Cord Involvement: An Atypical Manifestation of Aicardi–Goutières Syndrome
por: Samanta, Debopam, et al.
Publicado: (2019)

Aicardi-Goutières syndrome due to a paternal mosaic IFIH1 mutation
por: Tüngler, Victoria, et al.
Publicado: (2019)

Genetic Testing Contributes to Diagnosis in Cerebral Palsy: Aicardi-Goutières Syndrome as an Example
por: Beysen, Diane, et al.
Publicado: (2021)

Case Report: Aicardi-Goutières Syndrome Caused by Novel TREX1 Variants
por: Wu, De, et al.
Publicado: (2021)

Inflammatory cytokine production in a mouse model of Aicardi-Goutieres syndrome and neuroinflammation
por: Wiley, Clayton A., et al.
Publicado: (2022)

A case of Aicardi-Goutières syndrome caused by TREX1 gene mutation
por: Chenhan, Zheng, et al.
Publicado: (2023)

Aicardi–Goutières Syndrome with Congenital Glaucoma Caused by Novel TREX1 Mutation
por: Świerczyńska, Marta, et al.
Publicado: (2023)

Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi–Goutières syndrome patients carrying RNASEH2 mutations
por: Garau, Jessica, et al.
Publicado: (2021)

Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutières syndrome
por: Lim, Yoong Wearn, et al.
Publicado: (2015)

RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotransposition
por: Benitez‐Guijarro, Maria, et al.
Publicado: (2018)

Cutaneous Lesions as a Clue to the Etiology of Extensive Intracranial Calcifications: Aicardi-Goutières Syndrome
por: Zeng, Yi-Heng, et al.
Publicado: (2022)

SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome
por: Takanohashi, Asako, et al.
Publicado: (2022)

Aicardi-Goutières syndrome type 7 in a Chinese child: A case report
por: Lin, Shuang-Zhu, et al.
Publicado: (2023)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Modulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières Syndrome-Related SAMHD1
por: Zhao, Ke, et al.
Publicado: (2013)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hsob9cg1mt5do2flui05bab7av